Logo

Real world use of secukinumab for treatment of axial spondyloarthritis and psoriatic arthritis: nationwide results from the ATTRA registry

1, 2, 3, 4, 5, 6, 7, 8, 9; and the ATTRA Registry

  1. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic. mann@revma.cz
  2. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  3. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  4. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  5. Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
  6. Institute of Biostatistics and Analyses, Ltd., spinoff company of Masaryk University, Brno, Czech Republic.
  7. IIIrd Department of Internal Medicine, Faculty of Medicine and Dentistry, Palacký University, Olomouc, Czech Republic.
  8. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
  9. Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

CER11633 Submission on line
2019 Vol.37, N°2 - PI 0342, PF 0343
Letter

Free to view (click on article PDF icon to read the article)

Rheumatology Article

 

PMID: 30620295 [PubMed]

Received: 20/08/2018 - Accepted : 09/10/2018 - In Press: 04/01/2019 - Published: 19/03/2019